Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer’s disease

Title: Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer’s disease
Authors: Coughlan, Gillian T; Rubinstein, Zoe; Klinger, Hannah; Lopez, Kelly A; Hsieh, Stephaine; Boyle, Rory; Seto, Mabel; Townsend, Diana; Mayblyum, Danielle; Thibault, Emma; Jacobs, Heidi IL; Farrell, Michelle; Rabin, Jennifer S; Papp, Kate; Amariglio, Rebecca; Baker, Suzanne; Lois, Cristina; Rentz, Dorene; Price, Julie; Schultz, Aaron; Properzi, Michael; Johnson, Keith; Sperling, Reisa; Buckley, Rachel F
Source: Science Advances, vol 11, iss 10
Publisher Information: eScholarship, University of California
Publication Year: 2025
Collection: University of California: eScholarship
Subject Terms: 5202 Biological Psychology (for-2020); 32 Biomedical and Clinical Sciences (for-2020); 52 Psychology (for-2020); Alzheimer's Disease (rcdc); Neurosciences (rcdc); Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) (rcdc); Dementia (rcdc); Brain Disorders (rcdc); Clinical Research (rcdc); Aging (rcdc); Estrogen (rcdc); Neurodegenerative (rcdc); Women's Health (rcdc); Biomedical Imaging (rcdc); Acquired Cognitive Impairment (rcdc); 2.1 Biological and endogenous factors (hrcs-rac); Neurological (hrcs-hc); Humans (mesh); Alzheimer Disease (mesh); tau Proteins (mesh); Female (mesh); Aged (mesh); Middle Aged (mesh); Aged; 80 and over (mesh); Brain (mesh); Positron-Emission Tomography (mesh); Amyloid beta-Peptides (mesh); Estrogen Replacement Therapy (mesh); Hormone Replacement Therapy (mesh)
Time: eadt1288
Description: Elucidating the downstream impact of exogenous hormones on the aging brain will have far-reaching consequences for understanding why Alzheimer's disease (AD) predominates in women almost twofold over men. We tested the extent to which menopausal hormone therapy (HT) use is associated with later-life amyloid-β (Aβ) and tau accumulation using PET on N=146 baseline clinically normal women, aged 51 to 89 years. Women were scanned over a 4.5-year (SD, 2.1; range, 1.3 to 10.4) and 3.5-year (SD, 1.5; range, 1.2 to 8.1) period for Aβ and tau, respectively, ~14 years after the initiation of HT. In older women (aged >70 years), HT users exhibited faster regional tau accumulation relative to non-users, localized to the entorhinal cortex and the inferior temporal and fusiform gyri, with an indirect effect of HT on cognitive decline through regional tau accumulation. In younger women (aged
Document Type: article in journal/newspaper
File Description: application/pdf
Language: unknown
Relation: qt0586s8g8; https://escholarship.org/uc/item/0586s8g8; https://escholarship.org/content/qt0586s8g8/qt0586s8g8.pdf
DOI: 10.1126/sciadv.adt1288
Availability: https://escholarship.org/uc/item/0586s8g8; https://escholarship.org/content/qt0586s8g8/qt0586s8g8.pdf; https://doi.org/10.1126/sciadv.adt1288
Rights: CC-BY-NC
Accession Number: edsbas.CA648929
Database: BASE